CIK 0001824893
- Non-accelerated filer
- Smaller reporting company
Surrozen, Inc./DE
Sign in to watch- Ticker
- SRZN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 301374889
- Phone
- +1 650-475-2820
- Business address
- 171 OYSTER POINT BLVD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Consonance-HFW Acquisition Corp.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Open-market buy 10% owner bought 193,548 shares at $15.50 ($2,999,994)
- 4/A Open-market buy Director bought 193,548 shares at $15.50 ($2,999,994)
- 4 Open-market buy CFO and COO bought 1,474 shares
- 4 Open-market buy Chief Executive Officer bought 1,474 shares
- 4 Open-market buy Director bought 193,548 shares at $15.50 ($2,999,994)
- 4 Open-market buy 10% owner bought 193,548 shares at $15.50 ($2,999,994)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Financial Officer acquired 2,085 shares (grant or award)
- 4 Grant or award Exec. Vice President, Research acquired 2,085 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 2,046 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Executive Officer acquired 25,000 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 17,638 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 25,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 5 of 10 · 189 filings